Bok Financial Private Wealth, Inc. Bio Techne Corp Transaction History

Bok Financial Private Wealth, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$80.67 - $352.29 $193,608 - $845,496	2,400 Added 300.0%	3,200 $265,000
Q3 2022 Nov 07, 2022	BUY	$282.54 - $391.85 $226,032 - $313,480	800 New	800 $227,000
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $16,778 - $23,381	-52 Reduced 6.1%	800 $277,000
Q1 2022 May 09, 2022	SELL	$353.85 - $487.79 $14,507 - $19,999	-41 Reduced 4.59%	852 $369,000
Q4 2021 Feb 15, 2022	BUY	$456.15 - $525.06 $13,228 - $15,226	29 Added 3.36%	893 $462,000
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $384,367 - $465,592	864 New	864 $418,000
Q3 2021 Nov 09, 2021	SELL	$444.87 - $538.88 $372,356 - $451,042	-837 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$387.35 - $450.26 $12,395 - $14,408	32 Added 3.98%	837 $377,000
Q4 2020 Feb 01, 2021	BUY	$246.9 - $321.87 $198,754 - $259,105	805 New	805 $256,000
Q3 2020 Nov 06, 2020	SELL	$232.22 - $282.96 $186,937 - $227,782	-805 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$185.43 - $279.56 $149,271 - $225,045	805 New	805 $213,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Bok Financial Private Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Bok Financial Private Wealth, Inc. with notifications on news.